Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity

Medical Hypotheses

Volumn 57, Issue 2, 2001, Pages 192-200

  McCarty, M F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANXIOLYTIC AGENT; CAFFEINE; CATECHOLAMINE; ESTROGEN; GLUCOCORTICOID; INSULIN; LIPOPROTEIN LIPASE; SOMATOMEDIN; TESTOSTERONE; YOHIMBINE;

ADIPOCYTE; DIET THERAPY; DOWN REGULATION; ENZYME ACTIVITY; EXERCISE; FEMALE; HORMONAL THERAPY; HUMAN; INSULIN RELEASE; LOW CALORY DIET; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN EXPRESSION; REVIEW;

EID: 0034919878     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1317     Document Type: Article

References (129)

1. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity
2. Improvement of glucose lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity
3. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
4. Regional fat distribution - Implications for type II diabetes
5. Insulin resistance and body fat distribution
6. Pathophysiology and molecular mechanisms of visceral fat syndrome: The Japanese experience
7. Regional differences in the control of lipolysis in human adipose tissue
8. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis
9. The morphology and metabolism of intraabdominal adipose tissue in men
10. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline
11. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
12. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: Functional consequences
13. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men
14. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat
15. Insulin sensitivity and serum triglyceride level in obese white and black women: Relationship to visceral and truncal subcutaneous fat
16. Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women
17. Fatty acids and Insulin resistance
18. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
19. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects
20. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications
21. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin
22. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
23. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
24. Saturated fat intake and insulin resistance in men with coronary artery disease
25. Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: The Normative Aging Study
26. Usual dietary fat intake and insulin concentrations in healthy women twins
27. Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia
28. Whole body oxidation of dietary fatty acids: Implications for energy utilization
29. The diet and 15-year death rate in the seven countries study
30. Mediterranean diet and public health: Personal reflections
31. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
32. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
33. Effect of diet on fat cell size and hormone-sensitive lipase activity
34. The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB
35. Non-esterified fatty acid metabolism and postprandial lipaemia
36. Dietary fat and insulin sensitivity in a triethnic population: The role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)
37. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors
38. Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue
39. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men
40. Insulin-like growth factor-binding protein-1: A role in glucose counterregulation?
41. Insulin-like growth factor-binding protein-1 modulates blood glucose levels
42. Insulin-like growth factor binding proteins in the human circulation: A review
43. Serum free IGF-I during a hyperinsulinemic clamp following 3 clays of administration of IGF-I vs. saline
44. Drug therapy of postprandial hyperglycaemia
45. Treatment of visceral fat obesity
46. Patterns of hormonal release after glucose, protein, and glucose plus protein
47. Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females
48. The origins of Western obesity: A role for animal protein?
49. A moderate increase in daily protein intake causing an enhanced endogenous insulin secretion does not alter circulating levels or urinary excretion of dehydroepiandrosterone sulfate
50. Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis
51. Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity
52. Nutrition and somatomedin. XXIII. Molecular regulation of IGF-I by amino acid availability in cultured hepatocytes
53. Nutritional regulation of the insulin-like growth factors
54. Induction of insulin-like growth factor binding protein-1 gene expression in liver of protein-restricted rats and in rat hepatoma cells limited for a single amino acid
55. Physiological concentration of amino acids regulates insulin-like-growth-factor-binding protein 1 expression
56. Nutritional regulation of hormones and growth factors that control mammalian growth
57. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and-II, IGF binding protein-2, and serum albumin gene expression in rat
58. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults
59. Hypercholesterolemia and atherosclerosis: Effects of dietary protein
60. Preeclampsia and reproductive performance in a community of vegans
61. Does a vegetarian diet reduce the occurrence of diabetes?
62. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid
63. Postingestional effects of a high-protein diet on the regulation of food intake in monkeys
64. Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity
65. High glycemic index foods, overeating, and obesity
66. Effect of acetic acid and vinegar on blood glucose and insulin responses to orally administered sucrose and starch
67. Effect of neutralized and native vinegar on blood glucose and acetate responses to a mixed meal in healthy subjects
68. Delayed gastric emptying rate may explain improved glycaemia in healthy subjects to a starchy meal with added vinegar
69. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
70. Visceral adipose tissue: A critical review of intervention strategies
71. Exercise and insulin sensitivity: A review
72. Associations between physical activity and susceptibility to cancer: Possible mechanisms
73. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women
74. Potential impact on breast cancer risk of circulating insulin-like growth factor I modifications induced by oral HRT in menopause
75. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: A cross-over study
76. Experimental studies on lignans and cancer
77. Lipoprotein lipase gene expression in rat adipocytes is regulated by isoproterenol and insulin through different mechanisms
78. Beta-adrenergic-cyclic AMP signalling pathway modulates cell function at the transcriptional level in 3T3-F442A adipocytes
79. Impaired beta-adrenergic receptor-mediated regulation of gene expression in adipocytes from older rats
80. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise
81. Regional differences in adipose tissue metabolism between sedentary and endurance-trained women
82. The regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining
83. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements
84. Effects of caffeine ingestion on metabolism and exercise performance
85. Caffeine ingestion prior to incremental cycling to exhaustion in recreational cyclists
86. The effects of two levels of caffeine ingestion on excess postexercise oxygen consumption in untrained women
87. Adrenergic control of lipolysis and metabolic responses in obesity
88. Alpha 2-antagonist compounds and lipid mobilization: Evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers
89. Alpha-2 adrenoceptors in lipolysis: Alpha 2 antagonists and lipid-mobilizing strategies
90. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women
91. Adrenoceptor antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion from perfused rat pancreas
92. Catecholamine-induced lipolysis in adipose tissue of the elderly
93. Long term propranolol treatment and changes in body weight after myocardial infarction
94. Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients
95. Age-and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiomentry
96. Regional adipose tissue metabolism in men and postmenopausal women
97. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
98. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women
99. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women
100. Tobacco smoking and oestrogen replacement are associated with lower total and central fat in monozygotic twins
101. Effect of progestins on IGF-I serum level in estrogen-treated postmenopausal women
102. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus
103. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
104. Andropause
105. Effect of testosterone on abdominal adipose tissue in men
106. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men
107. Testosterone and regional fat distribution
108. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: Effects of testosterone
109. Androgens and abdominal obesity
110. Cortisol secretion in relation to body fat distribution in obese premenopausal women
111. Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity?
112. Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity?
113. Visceral fat accumulation: The missing link between psychosocial factors and cardiovascular disease?
114. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys
115. Effects of hormone replacement therapy and social stress on body fat distribution in surgically postmenopausal monkeys
116. Effect of an anxiolytic on lipid profile in non- insulin-dependent diabetes mellitus
117. Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial
118. Alprazolam blocks the naloxone- stimulated hypothalamo-pituitary-adrenal axis in man
119. The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam
120. Hypothalamic-pituitary-adrenal axis activity in panic disorder: Effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol
121. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans
122. Treatment with Kava-the root to ocombat stress
123. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
124. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients
125. Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects
126. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: A potential new insulin-sensitizing mechanism for thiazolidinediones
127. Pyruvate and hydroxycitrate/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively 'uncoupling' the oxidation of fatty acids
128. Hepatothermic therapy of obesity: Rationale and an inventory of resources